|
May 20
|
Genentech Provides Update on FDA Advisory Committee Meeting on Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
|
|
May 20
|
Roche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
|
|
May 17
|
Trump administration not backing down on Big Pharma pressure campaign
|
|
May 16
|
Trump Trade: Trump asks Apple to stop building iPhone plants in India
|
|
May 14
|
Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis
|
|
May 14
|
Roche warns Trump's drug price order puts US investment at risk
|
|
May 13
|
Ten-Year APHINITY Data Show Genentech’s Perjeta-based Regimen Reduced the Risk of Death by 17% in HER2-Positive Early-Stage Breast Cancer
|
|
May 13
|
Ten-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer
|
|
May 12
|
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
|
|
May 12
|
Roche and Genentech Announce New North Carolina Manufacturing Facility
|
|
May 12
|
Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices
|
|
May 10
|
Trump is hailing $2 trillion in new company investments. Most of it comes from Big Tech.
|
|
May 6
|
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity
|
|
Feb 20
|
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
|